The p75 neurotrophin receptor (p75NTR) is a transmembrane protein that binds nerve growth factor (NGF) and has multiple functions in the nervous system where it is expressed widely during the developmental stages of life, although expression decreases dramatically by adulthood. Expression of p75NTR can increase in pathological states related to neural cell death. p75NTR is a member of the tumour necrosis factor (TNF) receptor family and it consists of intracellular, transmembrane and extracellular domains which are different from other TNF receptors. Either by interacting with tropomyosin receptor kinase (Trk) receptors or via the independent binding of neurotrophin, p75NTR can induce neurite outgrowth and cellular survival or cell apoptosis through several complicated signal transduction pathways. Most of these signalling pathways remain to be elucidated. By interacting with different cellular factors, p75NTR can induce neuron growth cone collapse or regrowth. p75NTR is also expressed in a variety of glial populations. The many functions of p75NTR require further study.
Introduction
For over two decades, the p75 neurotrophin receptor (p75NTR) has been identified as a transmembrane protein that can bind nerve growth factor (NGF). 1 In subsequent studies it was found that, in addition to NGF, p75NTR also bound other members of the neurotrophin (NT) family, such as brainderived neurotrophic factor (BDNF), neurotrophin-3 (NT3), neurotrophin 4/5 (NT4/5) and even pro-neurotrophins. 2 p75NTR is a member of the tumour necrosis factor (TNF) receptor family, although its characteristics differ from other TNF receptors. The p75NTR name was selected because of its 75 kDa size. p75NTR has been found to play an important role in different biological systems, such as the immune, vascular and nervous systems. This review will describe its structure and its multiple functions within the nervous system.
Expression location
The expression of p75NTR varies among species and often changes during the life span of an organism. For example, it has been noted that p75NTR levels tend to be high and widely expressed in the developmental period of life but dramatically decrease when adulthood is Y Chen, J Zeng, Y Chen et al. The p75 neurotrophin receptor -roles in the nervous system reached. 3 In addition, p75NTR can be reexpressed to a significant degree in pathological states related to neural cell death. 3 In the adult mouse, p75NTR expression has been shown to be limited to a small subset of spinal cord ascending sensory axons, and also to a subset of dorsal root ganglia and some retinal cells, but not the cortex and cerebellum. 4 In contrast, p75NTR can be detected in rat cerebellum granule neurons. 5 It seems, therefore, that p75NTR expression appears to be temporally and spatially regulated by some kind of intrinsic mechanism.
Molecular structure
In 1996, Santee et al. 6 described the structure of the human p75NTR gene, identifying it as 75 000 base pairs (bp) in size and containing 10 exons and nine introns. Sharing an analogous structure and function with TNF receptor, p75NTR is a transmembrane protein that consists of an extracellular domain, a transmembrane domain and an intracellular domain. 1 The extracellular domain consists of a stalk domain connecting the transmembrane domain and four cysteine-rich repeat domains which are negatively charged, a property that facilitates neurotrophin binding. There is clear evidence that the third and fourth cysteine repeats are the binding site for neurotrophins, because the mutant form of p75NTR that lacks these two domains cannot bind neurotrophins. 7 The intracellular part of p75NTR is a global-like domain, known as the death domain, which consists of two sets of perpendicular helixes arranged in sets of three. It connects the transmembrane domain through a flexible linker region N-terminal domain. 8 It is possible that the flexibility of the linker domain plays an important role in multiple signal transduction. In addition, the intracellular, cytoplasmic region of p75NTR does not exhibit an intrinsic ligand-inducible enzymatic function, and this is distinctly different from tropomyosin receptor kinase (Trk) receptors which are NT receptors with higher affinity and specificity. 9 Although p75NTR is a member of the TNF receptor family, there are some obvious differences between p75NTR and other TNF receptors. First, the death domain of p75NTR is a type-2 molecule, which is different from the type-1 molecules of other TNF receptors 8 and, secondly, unlike other TNF receptors, p75NTR does not self-associate in solution. 8 These structural differences between p75NTR and the other TNF receptors lead to the different functions described below.
Survival or apoptosis INTERACTING WITH TRK RECEPTORS
Initially, p75NTR was just thought to be a coreceptor of the Trk receptor, which together enhanced the survival of neurons and glial cells. In pheochromocytoma 12 (PC12) cells, when co-expressed with TrkA, p75NTR can enhance NGF-induced neurite outgrowth and cellular survival. 10 In mouse hippocampal cells lacking p75NTR (p75NTR -/-), the activation of TrkA by NGF was not detectable and, moreover, neuroprotection by NGF against glutamate toxicity was abolished in p75NTR -/neurons. 11 Further research, however, has shown that this theory is too simplistic and it has now been proposed that p75NTR helps the Trk receptor to conduct the NT signal for neural survival, either by gathering NT and transporting it to the Trk receptor or by enhancing the affinity and specificity of Trk for NGF. For example, Zaccaro et al. 12 found evidence that p75NTR can alter the subdomain of the Trk receptor to expose a special site for NT binding; the binding Y Chen, J Zeng, Y Chen et al. The p75 neurotrophin receptor -roles in the nervous system affinity (K d ) of the Trk receptor was enhanced from 10 -9 M to 10 -11 M. In 2004, research into the crystal structure of p75NTR demonstrated that one p75NTR molecule binds two NGF molecules, thereby allowing p75NTR to bind another co-receptor, such as the Trk receptor, to form a hetero-complex. 13 The idea comes from the similarity of the extracellular domains of the p75NTR and TNF receptors, the latter of which usually binds a trimer of its ligands. 13 Recently, Wehrman et al. 14 have determined the threedimensional structure of a complete extracellular domain of TrkA forming a complex with NGF. They found that the complex has a crab-shaped homodimeric TrkA structure, but a mechanism for the p75NTR interaction was not obvious. Furthermore, they investigated the heterodimerization of membrane-bound TrkA and p75NTR and found that NGF dimerized TrkA and that p75NTR exists on the cell surface as a preformed oligomer that is not dissociated by NGF. 14 They found no evidence for a direct TrkA/p75NTR interaction. So, it may be proposed that TrkA and p75NTR most likely communicate through convergence of downstream signalling pathways and/or shared adaptor molecules, rather than through direct extracellular interactions.
INDEPENDENT BINDING OF NT
Although p75NTR acts as a co-receptor for the Trk receptor for survival signal transduction, it is believed that NT can induce apoptosis by binding to p75NTR independently, especially when the Trk receptor is not expressed. This idea has been tested by experiments on some cell lines that intrinsically do not express the Trk receptor or when the Trk receptors have been deleted. For example, Frade et al. 15 reported that, early in development, endogenous NGF causes the death of retinal neurons that express p75NTR but not TrkA. Furthermore, in some cases, when p75NTR is completely deleted, many cells are saved from apoptosis. 16 
SIGNAL TRANSDUCTION
As already mentioned, the function of p75NTR in both survival and apoptosis has been demonstrated by in vitro and in vivo experiments but, in terms of signal transduction, much remains to be elucidated.
Currently, ceramide, Ras/extracellular signal-regulated kinase (ERK), nuclear factor-kappa B (NF-κB) and Jun N-terminal kinase (JNK; also known as stress-activated protein kinase [SAPK]) are thought to be the predominant downstream factors involved in p75NTR signalling.
Ceramide is a structural element of the cell membrane and it can also act as a second messenger to induce tropic or apoptotic effects according to its level within the cell; it has been accepted as the second messenger molecule in the TNF-TNF receptor signalling pathway that induces cell death. 17 Evidence has been found that p75NTR leads to ceramide generation. For example, NGF caused the accumulation of ceramide in a neuroblast cell line that expressed p75NTR, but not in cells that just expressed Trk. 18 Stimulation of p75NTR induces the activation of neutral and/or acidic sphingomyelinases, which remove the polar head from sphingomyelin and generate ceramide. 18 In oligodendrocytes selectively expressing p75NTR, NGF treatment induced ceramide generation that was accompanied by cell apoptosis. 19 Frago et al. 20 reported that decreasing the endogenous level of ceramide could inhibit inner-ear cell apoptosis.
Activation of Trk leads to autophosphorylation of certain tyrosine residues Y Chen, J Zeng, Y Chen et al. The p75 neurotrophin receptor -roles in the nervous system within the intracellular domain and, subsequently, to activation of the Ras/ERK pathway, which is related to neurite outgrowth, elongation and branching. Some research has demonstrated that p75NTR can also activate the Ras/ERK pathway: the death domain of p75NTR has two tyrosine residues, Y337 and Y336, which are phosphorylated after p75NTR activation and the tyrosine phosphorylated p75NTR was demonstrated to activate Ras by means of the same adapter proteins as the Trk receptors. 21 Furthermore, ceramide 22 and Ras 23 promote robust neuronal survival by activating phosphatidylinositide 3-kinase (PI3-K), which has been linked to the juxtamembrane sequence of the cytoplasmic region of p75NTR. 24 p75NTR facilitates cell survival through novel signalling cascades that result in PI3-K-mediated Akt activation. 25 Many investigators have linked JNK (SAPK) to apoptosis and some have shown that the binding of NT to p75NTR can induce JNK activation. For example, in oligodendrocytes expressing p75NTR but not Trk, NGF binding to p75NTR that induced activation of JNK also induced apoptosis. 19 There was an increase in JNK activation and apoptosis after BDNF binding to p75NTR in cultured sympathetic neurons. 26 The crucial role of the JNK pathway in p75NTR signalling was further confirmed by blocking p75NTR from signalling via the JNK pathway or suppressing JNK activity itself, and this led to the inhibition of NGFdependent death. 27 Another kinase that is activated by p75NTR is NF-κB, which mainly viewed as an anti-apoptotic signalling factor. In Schwann cells selectively expressing p75NTR, NGF binding induced activation of NF-κB and anti-apoptotic effects. 28 Blocking p75NTR-mediated activation of NF-κB by ecdysone-inducible expression of a nondegradable mutant of IkappaBalpha significantly enhanced cultured PC12 cell apoptosis. 29 On the other hand, in neonatal rat oligodendrocytes, activation of NF-κB was shown to be associated with apoptosis. 30 As important as NF-κB and JNK are in neural cell survival and apoptosis, they do not tell the whole story. As p75NTR does not possess an intrinsic ligand-inducing enzymatic property, interacting proteins are necessary to transmit the p75NTR signal to downstream factors such as NF-κB and JNK. These interacting proteins include NTassociated cell death executor (NADE), neurotrophin receptor interacting factors (NRIF), TNF receptor associated factors (TRAFs), neurotrophin receptor-interacting MAGE homologue (NRAGE), receptor associated protein 2 (RIP2) and Schwann cell 1 (SC-1). 31
Growth cone elongation or collapse
It is now generally accepted that central nervous system (CNS) neurons cannot regrow naturally after neural injury. There are several reasons for this, such as scar formation, myelin inhibition and decreasing intrinsic regrowth potential. Myelin-derived inhibitory molecules, including Nogo, myelin-associated glycoprotein (MAG) and oligodendrocyte myelin glycoprotein (OMgp), all bind to the same receptor, the Nogo-66 receptor (NgR). But NgR alone cannot exert any inhibition because NgR has no intracellular domain, unless the NgR-LINGO-1-p75 complex has been formed. 32 But what is the definitive signalling pathway that leads to final growth cone collapse? Activation of Ras homologue member A (RhoA) has been frequently reported to be related to the inhibition of Y Chen, J Zeng, Y Chen et al. The p75 neurotrophin receptor -roles in the nervous system regeneration, hence when NgR, p75NTR and RhoA were silenced by siRNA, myelin inhibition was blocked dramatically. 33 However, RhoA cannot be shown directly to bind to the NgR-LINGO-1-p75 complex. Yamashita and Tohyama 34 found that the direct interaction of Rho guanine dissociation inhibitor (Rho-GDI) with p75NTR initiates the activation of RhoA. Usually, RhoA is bound to Rho-GDI so that it cannot be activated by guanine exchange factors (GEFs) but, after myelin binds to the NgR-LINGO-1-p75 complex, p75NTR can then bind to Rho-GDI with its fifth helix so that RhoA can be released from Rho-GDI. After being activated by GEF, RhoA activates ROCK (Rhoactivated kinase) and finally depolymerizes the actin filament, whereupon the growth cone then collapses. 34, 35 Nevertheless, when p75NTR binds NTs, RhoA becomes downregulated and this results in growth cone elongation. 36 Moreover, during the developmental period, p75NTR is important for neural growth and innervations; hence if p75NTR is completely deleted, growth and innervation is severely retarded. 37 However, it must be said that it is still not clear whether the Trk receptor plays a role by interacting with p75NTR during regeneration. In addition, Domeniconi et al. 38 found that MAG binding to cerebellar neurons induces α-and then γ-secretase proteolytic cleavage of p75NTR, and that this cleavage is necessary both for activation of Rho and inhibition of neurite outgrowth. Contrary evidence from Ahmed et al., 39 however, reported that TNF-α converting enzyme (TACE)-induced regulated intramembranous proteolysis of p75NTR abrogates axon growth inhibitory signalling, thereby disinhibiting CNS axon/neurite growth.
Function in glia
The p75NTR is expressed in a variety of glial populations, especially during development and after injury, however few studies have focused on the various roles of glial p75NTR. The lack of studies in this area is due, in part, to the complicated functions of p75NTR in neurons and also the lack of proper models with which clearly to dissect the roles of p75NTR in neurons and glia. 40 Among glial cells, Schwann cells have been the most extensively studied for p75NTR signalling. Schwann cells express high levels of p75NTR in developing and regenerating peripheral nerves, although the specific role of p75NTR in mediating myelination is unclear. Cosgaya et al. 41 demonstrated that the enhancement of myelin formation in co-cultures of dorsal root ganglia neurons and Schwann cells by endogenous BDNF is mediated by p75NTR receptors. 41 Chan et al. 42 showed that the polarity protein, Par-3, directly associates and recruits p75NTR to the axon-glial junction, forming a complex necessary for myelination. To elucidate the in vivo function of p75NTR in Schwann cells during remyelination after peripheral nerve injury, Tomita et al. 43 established a new animal model for p75NTR-deficient Schwann cell transplantation in nude mice. They found that the mice that received the p75 -/-Schwann cells showed impaired myelination and lower numbers of the retrogradelabelled motor neurons at 6 and 10 weeks after injury. Besides the role in remyelination after injury, p75NTR may also contribute to extracellular matrix remodelling. For example, Sachs et al. 44 revealed a novel pathogenic mechanism by which p75NTR regulates degradation of cAMP and perpetuates scar formation after injury. They reported that p75NTR, which was upregulated after tissue injury, blocked fibrinolysis by down-regulating the serine protease, tissue plasminogen activator, and 44 The function of p75NTR in oligodendrocytes, the myelinating cells of the CNS, is different from what occurs in Schwann cells. In 1996, oligodendrocytes were shown to undergo p75NTR-mediated apoptosis in vitro. 19 This was associated with Rac GTPase activation, 27 JNK phosphorylation 27 and caspase activation. 45 Similarly, in vivo, p75NTR-mediated oligodendrocyte apoptosis occurs after spinal cord injury. 46, 47 However, p75NTR does not always mediate the death of oligodendrocytes 48 and evidence for p75NTRindependent oligodendrocyte death has also been found. 49 So, p75NTR may play a more crucial role in the regulation of peripheral myelination rather than central myelination.
In the intact CNS of adult rats, p75NTR is expressed in a restricted population of astrocytes, 50 however, after injury there is strong up-regulation of p75NTR on accumulating astrocytes. 51 There is uncertainty about the role of p75NTR in pathological conditions, although one possibility may be that p75NTR regulates the proliferation of astrocytes to restrict glial scar formation after CNS injury.
Conclusion
The increase in knowledge of the structure and function of p75NTR means that a more complete picture now exists of its role in the nervous system and, clearly, this can lead to the discovery of other related molecules involved in other intricate signalling mechanisms. As described in this review, p75NTR is only expressed in small subsets of cells within the nervous system. Suppression of p75NTR does not promote regeneration of an injured spinal cord in the mouse, which suggests that some other p75NTR homologues are involved. For example, the NT receptor homologue-2 (NRH2) may be one of these candidates as it can enhance the affinity of Trk for NGF. 52 Recently, TROY, a member of the TNF receptor superfamily and also known as TAJ, has been found to be a p75NTR homologue and it seems to play a more important role in regeneration inhibition and is more widely expressed in the nervous system than p75NTR. 4 Clearly, further investigation is required fully to elucidate the role of p75NTR in the development and maintenance of the nervous system.
